WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 2107

Legislative bill overview

SB 2107 addresses lung cancer screening in Hawaii by establishing or modifying protocols, access, or insurance coverage requirements for low-dose CT screening. The bill was recently introduced in the Hawaii State Senate and referred to the Health and Human Services (HHS) and Consumer Protection and Commerce (CPN) committees for review.

Why is this important

Lung cancer remains one of the deadliest cancers in Hawaii and nationally, with earlier detection significantly improving survival rates. Low-dose CT screening is clinically proven effective for high-risk populations but faces barriers including cost, awareness, and insurance coverage gaps. This legislation could expand preventive health access and reduce disease burden in the state.

Potential points of contention

  • Insurance mandate scope: Whether the bill requires private insurers, public programs (like Medicaid/Medicare), or both to cover screening, and what financial burden this places on different sectors
  • Eligibility criteria: Disputes over who qualifies for screening (age ranges, smoking history thresholds) and whether criteria align with federal clinical guidelines or are broader/narrower
  • Implementation costs: Healthcare system capacity to perform additional screenings and whether state funding is adequate, or if costs shift to providers or patients

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.